Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain

Synapse

Volumn 25, Issue 1, 1997, Pages 80-92

  Benes, Francine M ^a,b   Todtenkopf, Mark S ^a   Taylor, Jill B ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

dopamine; miswiring; nonpyramidal neurons; pyramidal cells

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; ENZYME LOCALIZATION; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; INTERNEURON; NEUROPIL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

CELL SIZE; GYRUS CINGULI; HUMANS; NERVE FIBERS; PYRAMIDAL CELLS; SCHIZOPHRENIA; TYROSINE 3-MONOOXYGENASE;

EID: 0031030222     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199701)25:1<80::AID-SYN10>3.0.CO;2-2     Document Type: Article

References (71)

1. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E., and Jones, E.G. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry, 52:258-278.
2. Akil, M., and Lewis, D.A. (1993) The dopaminergic innervation of monkey entorhinal cortex. Cereb. Cortex, 3:533-550.
3. Beaudet, A., and Descarries, L. (1984) Fine structure of monoamine axon terminals in cerebral cortex. In: Monoamine Innervation of Cerebral Cortex. L. Descarries, T.R. Reader, and H.H. Jasper, eds. Alan R. Liss, Inc., New York, pp. 77-94.
4. Benes, F.M. (1988) Post-mortem structural analyses of schizophrenic brain. Study designs and the interpretation of data. Psychiatr. Dev., 6:213-226.
5. Benes, F.M. (1993a) Relationship of cingulate cortex to schizophrenia and other psychiatric disorders. In: Neurobiology of Cingulate Cortex and Limbic Thalamus. B.A. Vogt and M. Gabriel, eds. Birkhauser, Inc., Boston, pp. 581-605.
6. Benes, F.M. (1993b) Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr. Bull., 19:537-549.
7. Benes, F.M. (1995) Is there a neuroanatomic basis for schizophrenia? Neuroscientist, 1:104-115.
8. Benes, F.M. (1996) The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J. Psychiat. Res., in press.
9. Benes, F.M., and Bird, E.D. (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psychiatry, 44:608-616.
10. Benes, F.M., Davidson, J., and Bird, E.D. (1986) Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry, 43:31-35.
11. Benes, F.M., Majocha, R., Bird, E.D., and Marrotta, C.A. (1987) Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch. Gen. Psychiatry, 44:1017-1021.
12. Benes, F.M., McSparren, J., Bird, E.D., San Giovanni, J.P., and Vincent, S.L. (1991) Deficits in small interneurons in prefrontal and anterior cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry, 48:996-1001.
13. Benes, F.M., Sorensen, I., Vincent, S.L., Bird, E.D., and Sathi, M. (1992a) Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb. Cortex, 2:503-512.
14. Benes, F.M., Vincent, S.L., Alsterberg, G., Bird, E.D., and San Giovanni, J.P. (1992b) Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci., 12:924-929.
15. Benes, F.M., Vincent, S.L., and Molloy, R. (1993) Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons of rat medial prefrontal cortex. Synapse, 15:285-295.
16. Benes, F.M., Vincent, S.L., and Molloy, R. (1996) Increased interaction of dopamine (DA) varicosities with GABA cells occurs progressively in rat medial prefrontal cortex (mPFC) from birth to adulthood. Synapse, 23:237-245.
17. Benowitz, L., and Routtenberg, A. (1987) A membrane phosphoprotein associated with neural development, axonal regeneration, phospholipid metabolism and synaptic plasticity. Trends Neurosci., 10:527-532.
18. Bird, E.D., Spokes, E.G.S., and Iversen, L.L. (1979) Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain, 102:347-360.
19. Bruinink, A., Lichtensteiger, W., and Schlumpf, M. (1983) Pre-and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain. J. Neurochem., 40:1227-1236.
20. Carlsson, A. (1978a) Does dopamine have a role in schizophrenia? Biol. Psychiatry, 13:3-21.
21. Carlsson, A. (1978b) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am. J. Psychiatry, 135:164-173.
22. Cross, A.J., Crow, T.J., and Owen, F. (1981) 3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology (Berlin), 74:122-124.
23. Crow, T.J., Baker, H.F., Cross, A.J., Joseph, M.H., Lofthouse, R., Longden, A., Owen, F., Riley, G.J., Glover, V., and Killpack, W.S. (1979) Monoamine mechanisms in chronic schizophrenia: Post-mortem neurochemical findings. Br. J. Psychiatry, 134:249-256.
24. Deskin, R., Seidler, F.J., Whitmore, W.L., and Slotkin, T.A. (1981) Development of α-noradrenergic and dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain. J. Neurochem., 36:1683-1690.
25. Deutch, A.Y., Gruen, R.J., and Roth, R.H. (1989) The effects of perinatal diazepam exposure on stress-induced activation of the mesotelencephalic dopamine system. Neuropsychopharmacology, 2:105-114.
26. Feighner, J.P., Robins, E., and Guze, S.B. (1972) Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry, 26:57-63.
27. Fuxe, K., Cintra, A., Härfstrand, A., Agnati, L.F., Kalia, M., Zoli, M., Wikstrom, A.C., Okret, S., Aronsson, M., and Gustafsson, J.A. (1987) Central glucocorticoid receptor immunoreactive neurons: New insights into the endocrine regulation of the brain. Ann. N.Y. Acad. Sci., 512:362-393.
28. Gaspar, P., Berger, B., Febvret, A., Vigny, A., and Henry, J.P. (1989) Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine beta-hydroxylase. J. Comp. Neurol., 279:249-271.
29. Gelman, R.L., and Aghajanian, G.K. (1993) Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res., 600:63-73.
30. Goldman-Rakic, P.S., Leranth, C., William, S.M., Mons, N., and Geffard, M. (1989) Dopmamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A., 86:9015-9019.
31. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24.
32. Jones E.G. (1984) Laminar distribution of cortical efferent cells. In: Cerebral Cortex. A. Peters and E.G. Jones, eds. Plenum Press, New York, pp. 521-548.
33. Joyce, J.N., Lexow, N., Bird, E., and Winokur, A. (1988) Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse, 2:546-557.
34. Kalsbeek, A., Voorn, P., Buijs, R.M., Pool, C.W., and Uylings, H.B.M. (1988) Development of the dopaminergic innervation in the prefrontal cortex of rat. J. Comp. Neurol., 269:58-72.
35. Kornhuber, J., Riederer, P., Reynolds, G.P., Beckmann, H., Jellinger, K., and Gabriel, E. (1989) 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J. Neural Transm., 75:1-10.
36. Lavielle, S., Tassin, J.P., Thierry, A.M., Blanc, G., Herve, D., Barthelemy, C., and Glowinski, J. (1978) Blockade by benzodiazepines of the selective high increase in dopamine turnover by stress in mesocortical dopaminergic neurons of the rat. Brain Res., 168:585-594.
37. Lee, T., and Seeman, P. (1980) Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am. J. Psychiatry, 137:191-197.
38. Lewis, D.A., Campbell, M.J., Foote, S.L., Goldstein, M., and Morrison, J.H. (1987) The distribution of tyrosine hydroxylase immunoreactive fibers in primate neocortex is widespread but regionally specific. J. Neurosci., 7:279-290.
39. Mackay, A.V.P., Iversen, L.L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I., and Snyder, S.H. (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry, 39:991-997.
40. Maura, G., Giardi, A., and Raiteri, M. (1988) Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J. Pharmacol. Exp. Ther., 247:680-684.
41. Meltzer, H.Y., Matsubara, S., and Lee, J.C. (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. J. Pharmacol. Exp. Ther., 251:238-246.
42. Meshul, C.K., Janowsky, A., Casey, D.E., Stallbaumer, R.K., and Taylor, B. (1992) Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens and medial prefrontal cortex. Psychopharmacology (Berlin), 106:45-52.
43. Morilak, D.A., Garlow, S.J., and Ciaranello, R.D. (1993) Immunocytochemical localization and description of neurons expressing serotonin-2 receptors in the rat brain. Neuroscience, 54:701-717.
44. Noack, H.J., and Lewis, D.A. (1989) Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex. Brain Res., 500:313-324.
45. Owen, F., Crow, T.J., Poulter, M., Cross, A.J., Longden, A., and Riley, G.J. (1978) Increased dopamine-receptor sensitivity in schizophrenia. Lancet 2:223-225.
46. Reynolds, G.P. (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature, 305:527-529.
47. Rosenberg, D.R., and Lewis, D.A. (1994) Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: A tyrosine hydroxylase immunohistochemical study. Biol. Psychiatry, 36:272-277.
48. Roth, R.H., Tam, S.Y., Ida, Y., Yang, J.X., and Deutch, A.Y. (1988) Stress and the mesocorticolimbic dopamine systems. Ann. N.Y. Acad. Sci., 537:138-147.
49. Rowlands, G.J., and Roberts, P.J. (1980) Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro. Eur. J. Pharmacol., 242:241-247.
50. Royce, G.J. (1983) Cortidcal neurons with collateral projections to both the caudate nucleus and the centromedian-parafascicular thalamic complex: A fluorescent retrograde double-labelling study in the cat. Exp. Brain Res., 50:157-165.
51. Samson, Y., Wu, J.J., Friedman, A.H., and Davis, J.N. (1990) Catecholaminergic innervation of the hippocampus in the cynomolgus monkey. J. Comp. Neurol., 298:250-263.
52. Schwarcz, R., Creese, I., Coyle, J.T., and Snyder, S.H. (1978) Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature, 271:766-768.
53. Schwartz, M.A., Wyatt, R.J., Yang, H.Y.T., and Neff, N.H. (1974) Multiple forms of brain monoamine oxidase in schizophrenic and normal individuals. Arch. Gen. Psychiatry, 31:557-560.
54. Seeman, P., and Niznik, H.B. (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J., 4:2737-2744.
55. Seguela, P., Watkins, K.C., and Descarries, L. (1988) Ultrastructural features of dopamine axon terminals in the anteromedial and suprarhinal cortex of rat. J. Comp. Neurol., 289:11-22.
56. Selemon, L.D., Rajkowska, G., and Goldman-Rakic, P.S. (1995) Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry (in press).
57. Sheldon, P.W., and Aghajanian, G.K. (1991) Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: Evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse, 9:208-218.
58. Tam, S.Y., and Roth, R.H. (1990) Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization. J. Pharmacol. Exp. Ther., 252:989-996.
59. Thierry, A.M., Tassin, J.P., Blanc, G., andGlowinski, J. (1976) Selective activation of the mesocortical DA system by stress. Nature, 263:242-244.
60. Toru, M., Nishikawa, T., Mataga, N., and Takashima, M. (1982) Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J. Neural Transm., 54:181-191.
61. Van Hoesen, G.W., Morecraft, R.J., and Vogt, B.A. (1993) Connections of the monkey cingulate cortex. In: Neurobiology of Cingulate Cortex and Limbic Thalamus. B.A., Vogt and M. Gabriel, eds. Birkhauser, Boston, pp. 249-284.
62. Verney, C., Berger, B., Adrien, J., Vigny, A., and Gay, M. (1982) Development of the dopaminergic innervation of the rat cerebral cortex. A light microscopic immunocytochemical study using anti-tyrosine hydroxylase antibodies. Dev. Brain Res., 5:41-52.
63. Verney, C., Alvarez, C., Gerrard, M., and Berger, B. (1990) Ultrastructural double-labelling study of dopamine terminals and GABA-containing neurons in rat anteromedial cortex. Eur. J. Neurosci., 2:960-972.
64. 2 receptors in rat medial prefrontal cortex. J. Neurosci., 13:2551-2564.
65. Vincent, S.L., Adamec, E., Sorensen, I., and Benes, F.M. (1994) The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse, 17:26-35.
66. Vincent, S.L., Khan, Y., and Benes, F.M. (1995) Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse, 19:112-120.
67. Waddington, J.L., Cross, A.J., Gamble, S.J., and Bourne, R.C. (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science, 220:530-532.
68. Weibel, E.R. (1979) Sterological Methods. Practical methods for Biological Morphometry. Academic Press, New York, pp.
69. Williams, S.M., and Goldman-Rakic, P.S. (1993) Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb. Cortex, 3:199-222.
70. Wise, C.D., and Stein, L. (1973) Dopamine-β-hydroxylase deficits in the brains of schizophrenic patients. Science, 181:344-347.
71. Wyatt, R.J., Schwartz, M.A., Erdelyi, E., and Barchas, J.D. (1975) Dopamine β-hydroxylase activity in brains of chronic schizophrenic patients. Science, 187:368-370.